Sangamo Therapeutics (SGMOQ) Stock Price, News & Analysis
Company Description
SGMOQ has gained 44.4% over the past year. Shares last traded at $0.0650.
On a trailing twelve-month basis, Sangamo Therapeutics reported revenue of $39.6M with net income of -$122.9M and diluted earnings per share of $-0.44. The company operates at a net profit margin of -310.8%.
This page collects what Stock Titan holds for SGMOQ, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sangamo Therapeutics (SGMOQ) last traded at $0.0650, down 1.52% from the previous close. Over the past 12 months, SGMOQ has gained 44.4%.
SGMOQ Rankings
Latest News
SEC Filings
Sangamo Therapeutics has filed 1 recent SEC filing, including 1 Form 8-K. The most recent filing was submitted on July 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SGMOQ SEC filings →
Financial Highlights
Sangamo Therapeutics generated $39.6M in revenue over the trailing twelve months, operating income reached -$121.2M (-306.5% operating margin), and net income was -$122.9M, reflecting a -310.8% net profit margin. Diluted earnings per share stood at $-0.44. The company generated -$97.2M in operating cash flow. With a current ratio of 0.84, short-term liquidity bears monitoring.